Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
T1 + T2 + T3
- Development stage
- Unknown
- Administration
- Oral
01
Overview
T1 + T2 + T3 is a combination of three thyroid hormones. T1 and T2 are hormone precursors and byproducts of thyroid hormone synthesis that do not act on the thyroid hormone receptor and appear to be inert. T3 (triiodothyronine) is the active form of thyroid hormone that directly affects metabolism. This combination is found in natural desiccated thyroid medications along with T4. T3 is the biologically active thyroid hormone that enters cells from the bloodstream and increases metabolism, while T1 and T2 may have other physiological roles. T2 specifically may have benefits for mitochondrial and ovarian health in women with hypothyroidism.
02
Targets
THR (Thyroid hormone receptor)
Beyond the preview
Go deeper on T1 + T2 + T3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T1 + T2 + T3.